Neurocrine Biosciences



Ebit تغيير تاريخ
AbbVie USD 5.65B 407M 2025-03
Acadia Pharmaceuticals USD 19.29M 12.3M 2025-03
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
ALKERMES USD 13.79M 148.9M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amgen USD 3.6B 434M 2025-03
Biogen USD 582.8M 61.3M 2025-03
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Cytokinetics USD -155631000 16.59M 2025-03
Dynavax Technologies USD -23630000 22M 2025-03
Exelixis USD 186.86M 23.4M 2025-03
Gilead Sciences USD 2.89B 221M 2025-03
Halozyme Therapeutics USD 182.75M 19.56M 2024-12
Incyte USD 283.64M 92.62M 2025-03
Ionis Pharmaceuticals USD -146000000 36M 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Pfizer USD 5.93B 1.31B 2025-03
Prothena USD -64897000 1.62M 2024-12
Regeneron Pharmaceuticals USD 913.7M 661M 2025-03
Repligen USD 23.4M 1.59M 2025-03
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Teva Pharmaceutical Industries USD 946M 222M 2025-03
Ultragenyx Pharmaceutical USD -142939000 20.66M 2025-03
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Neurocrine Biosciences - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.